Fumitaka Mizoguchi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblasts.
Journal: Immunological medicine
Published: May 15, 2024
Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 30, 2024
Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides.
Journal: Frontiers in medicine
Published: January 30, 2023
Correction: CD34+THY1+ synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro.
Journal: Arthritis research & therapy
Published: September 24, 2022
Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosis.
Journal: Journal of cachexia, sarcopenia and muscle
Published: December 21, 2021
CD34+THY1+ synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro.
Journal: Arthritis research & therapy
Published: October 22, 2021
Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 18, 2021
Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts.
Journal: Rheumatology (Oxford, England)
Published: September 14, 2021
Similarity of Response to Biologics Between Elderly-onset Rheumatoid Arthritis (EORA) and Non-EORA Elderly Patients: From the FIRST Registry.
Journal: The Journal of rheumatology
Published: January 25, 2021
Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome.
Journal: Rheumatology (Oxford, England)
Published: October 24, 2020
Difficult-to-treat rheumatoid arthritis with respect to responsiveness to biologic/targeted synthetic DMARDs: a retrospective cohort study from the FIRST registry.
Journal: Clinical and experimental rheumatology
Published: August 06, 2020
Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies.
Journal: Nature communications
Published: July 25, 2020
Last Updated: 09/26/2026